Vaccination

Novak Djokovic repeated his hardline refusal to get a Covid-19 vaccination Saturday as he resigned himself to sitting out the season’s last Grand Slam at the US Open. Djokovic was deported from Melbourne in January over his single-minded but controversial stance, forcing him to abandon an assault on a 10th Australian Open title. With no sign of the US authorities relaxing their rule requiring all visitors to be vaccinated, the 35-year-old Djokovic admitted Saturday that Wimbledon, which starts Monday, will be his last Slam of 2022. Wimbledon 2022: Novak Djokovic to Bring Curtain up on All England Championships When asked if he had completely closed his mind to getting vaccinated, he was unequivocal. “Yes,” he said. Djokovic was US Open champion in 2011, 2015 and 2018. He has 20 Slams to his name, two fewer than old rival Rafael Nadal. Last year, defeat in the New York final to Daniil Medvedev robbed him of the opportunity to become the first man since 1969 to clinch a … [Read more...] about Wimbledon 2022: Novak Djokovic Repeats No Vaccination Stance as US Open Slips Away

June 28, 2022 10:20 Korea's first homegrown COVID-19 vaccine is going through the final stage of approval. The Ministry of Food and Drug Safety on Monday said a review committee has preliminarily approved SKYCovione (or GBP510) by SK Bioscience, and a final review session this week is expected to give it the green light. GBP510 was developed by SK Bioscience and the University of Washington's Institute for Protein Design. Like the Novavax vaccine, it is a recombinant-protein vaccine based on the same technology used to make flu or Type B hepatitis vaccines. It differs from both mRNA vaccines like Pfizer and Moderna or viral-vector vaccines like AstraZeneca and is given twice at an interval of four weeks. It can be kept in normal cold storage of 2-8 degrees Celsius. "Fourteen days after two doses, those who got GBP510 were found to have 2.93 times more neutralizing antibodies than those in the control group who were given AstraZeneca," the review committee said. … [Read more...] about Korean COVID Vaccine Posed for Approval

Serum Institute of India (SII) has applied to the country’s drug regulator seeking market authorisation to manufacture indigenously developed India’s first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer, official sources said on Wednesday. The Pune-based firm has applied for market authorisation after completing the phase 2/3 clinical trial with support of the Department of Biotechnology to ensure its early availability in the country, they said. In the application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, director (government and regulatory affairs) at SII, said the vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1000 times higher than the baseline against all targeted HPV types and in all dose and age groups. The SII is also learnt to have made a presentation before the working group of HPV under the chairmanship of Dr NK Arora constituted separately by the NTAGI to review the data and usefulness of … [Read more...] about SII Seeks from DCGI Market Authorisation for India’s First QHPV Vaccine Against Cervical Cancer

Serum Institute of India has urged the Union government to include Covovax in the National COVID-19 Vaccination programme for inoculating those aged 12 years and above, official sources said on Tuesday. The Pune-based SII said it wants to provide Covovax to private hospitals at Rs 900 per dose plus GST and is also waiting for directions to supply the vaccine to the Centre but has not mentioned the price. India's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain conditions on March 9 and for 18 years and above on December 28. In a letter to Health Secretary Rajesh Bhushan, Director, Government and Regulatory Affairs at SII Prakash Kumar Singh said private companies, educational institutes, social organizations, Central government organizations and Public sector undertakings are making requests for Covovax to inoculate their staffers, families and children, an official source said. Singh is also learnt to … [Read more...] about Serum Institute Seeks Covovax’s Inclusion in Covid Vaccination Drive for 12 Years & Above

Actress Kangana Ranaut on Wednesday shared photographs of her parents getting their second dose of the vaccine for Covid-19 prevention in her home state Himachal Pradesh. The actress said that she is now waiting for her turn to get vaccinated. Sharing photographs of her mother and father getting the vaccine, Kangana tweeted: “My parents got their second dose of the vaccine today in Himachal Pradesh, no fever no weakness no other symptoms they are feeling quiet good and happy… Waiting for my turn now.” My parents got their second dose of the vaccine today in Himachal Pradesh no fever no weakness no other symptoms they are feeling quiet good and happy…. pic.twitter.com/iVAsSydKdL — Kangana Ranaut (@KanganaTeam) April 7, 2021 Kangana will next be seen in her upcoming film Thalaivi where she plays late Tamil Nadu chief minister J. Jayalalithaa. The film is slated to release in Hindi, Tamil and Telugu on April 23. The actress has been shooting for her another upcoming … [Read more...] about Kangana Ranaut Shares Pics of Parents Getting Covid Vax, Says ‘Waiting for My Turn’

The patient walked into the Washoe County community testing station in the US state of Nevada on April 18 with a sore throat, dry cough and a headache, but no reason to worry. He was only 25, had no prior medical conditions, and although the PCR nasal-swab test for Covid-19 he took came back positive, he was soon feeling well again. Thirty-five days later, he was rushed to the emergency room, short of breath and with a raging fever, and placed on oxygen support. He had become the first confirmed US case of Covid-19 reinfection. Up to now, there have been only a handful of similar cases worldwide, and experts say it is too early to draw sweeping conclusions from such a small headcount. Also Read: Contracting Coronavirus Outdoors is Rare But That Shouldn’t Stop You From Wearing a Mask But the prospect of getting reinfected with Covid-19 — and getting even sicker the second time around — could have a significant impact on how governments chart the path out of the pandemic. … [Read more...] about Coronavirus Reinfection is Very Much a Possibility. But is This a Cause of Worry?

District Collector P.S. Girisha on Monday said dairy farmers should be encouraged to get their livestock vaccinated against brucellosis. The Collector was launching the “Brucellosis Vaccine “ poster as part of the National Livestock Disease Vaccination Programme undertaken by the Department of Animal Husbandry. Mr. Girisha said that the brucellosis vaccination programme was being implemented across the country. Dairy farmers should be cautioned by the officials and field staff concerned about the dangerous effects of the disease on their livestock. “Vaccines are needed to prevent brucellosis. These vaccines should only be given to calves over four months and under eight months of age. Veterinarians would go to the owners of the livestock and vaccinate the animals free of cost. Once vaccinated, cattle do not develop brucellosis for the rest of their lives. The first phase of vaccination was completed last March and the programme would be conducted in three phases this year,” he … [Read more...] about Dairy farmers in Andhra Pradesh cautioned against brucellosis among livestock

A furious mom-of-four is considering severing ties with a set of fellow parents after they failed to disclose that their daughter had chickenpox in a situation that left her clinically vulnerable child dangerously exposed to the virus. Vaccines have played a significant role in changing the impact of chickenpox in the U.S. Data from the CDC shows prior to the introduction of the U.S. Vaccination Program in 1996, chickenpox led to more than 10,000 hospitalizations and 100 deaths every year, with over 4 million people contracting the virus . Since then, however, there has been a 90 percent decrease in deaths linked to chickenpox as well as 84 percent less hospitalizations and 92 percent fewer cases. It's a hugely positive shift, but some caution is still required when it comes to dealing with outbreaks of the virus, as one angry mother's story demonstrates. Writing in a post shared to Mumsnet under the handle JustLyra, the woman explained that the youngest of her kids … [Read more...] about Mom hosting sleepover despite daughter’s chickenpox branded “unforgivable”

People must extend support to the Nikshay Mitr Abhiyan so that tuberculosis could be eliminated, said Union Health Minister Mansukh Mandaviya here on Sunday. On a two-day visit to the city, he launched the interim report of the Indian catalogue of Mycobaterium TB mutation and their association with drug resistance at the Indian Council of Medical Research (ICMR), National Institute for Research in Tuberculosis, besides a booklet on nutritional support in Tamil for the patients. He said there were still 50,000 people who had TB but only 5% of them had consented to support the scheme. As much as 35% had not accepted it yet. “Only with your support, like in COVID, can we overcome together this hurdle to the nation’s progress,” he said. Earlier in the day, he flagged off a bicycle rally, organised by National Health Mission, to emphasise ‘Healthy India, Fit India’ in which State Health Secretary P. SenthilKumar, dean of Omandurar Medical College R. Jayanthi, besides several Union … [Read more...] about Union Health Minister seeks people’s support to eradicate TB

close Video Fox News Flash top headlines for June 27 Fox News Flash top headlines are here. Check out what's clicking on Foxnews.com. NEW You can now listen to Fox News articles! AstraZeneca said on Monday two of its existing therapies were recommended for treating patients with some forms of high-risk breast cancers in the European Union, in a boost to the company's oncology portfolio. Lynparza, a cancer drug developed jointly with U.S.-based Merck, was backed for standalone use or in combination with endocrine therapy in adults with a form of genetically mutated early-stage breast cancer. The drug , which has received a similar recommendation in the United States in March, is a key asset for AstraZeneca. It was recommended in patients with low-to-normal levels of a protein known as HER2 that is the target of several new therapies. ASTRAZENECA TO BUY ALEXION FOR $39 BILLION TO EXPAND IN IMMUNOLOGY The logo … [Read more...] about AstraZeneca gets EU backing for targeted breast cancer therapies